Protagonist Therapeutics, Inc. (PTGX)

85.25 -2.09 (-2.39%) USD  |  NASDAQ  |  Jan 02, 14:02
More

Protagonist Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
MannKind Corp. Upgrade